Interleukin enhancer-binding factor 3 (ILF3) (AA 756-805) Antikörper
Kurzübersicht für Interleukin enhancer-binding factor 3 (ILF3) (AA 756-805) Antikörper (ABIN6737688)
Target
Alle Interleukin enhancer-binding factor 3 (ILF3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 756-805
-
Spezifität
- Human ILF3
-
Homologie
- Percent identity by BLAST analysis: Human, Dog (100%) Bovine, Horse, Pig (92%) Xenopus (91%) Rabbit, Guinea pig (85%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa756-805 of human ILF3 (Q12906, NP_036350). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Marmoset, Dog, Opossum, Lizard (100%), Elephant, Bovine, Bat, Horse, Pig (92%), Xenopus (91%), Rabbit, Guinea pig (85%), Mouse, Rat (78%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: WB
Usage: ELISA titer using peptide based assay: 1:62500. Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1:50000 - 100000 as second antibody. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled Water.
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- Interleukin enhancer-binding factor 3 (ILF3)
-
Andere Bezeichnung
- NF90 / ILF3
-
Hintergrund
-
Name/Gene ID: ILF3
Synonyms: ILF3, CBTF, DRBF, DRBP76, MMP4, NF-AT-90, NF90, NFAR2, Nuclear factor nf90, M-phase phosphoprotein 4, TCP110, MPHOSPH4, NF110b, NF90a, NF90b, NFAR-1, TCP80, NF110, NFAR -
Gen-ID
- 3609
-
NCBI Accession
- NP_036350
-
UniProt
- Q12906
-
Pathways
- M Phase
Target
-